Leadership Overview
Arcera has 4 executives leading key functions including strategy, financial oversight, human capital management, and legal compliance.
Committed to advancing global health outcomes, Arcera bridges investment, talent, and expertise to mitigate complex healthcare challenges while fostering sustainable growth through a diverse portfolio of branded medicines.
Committed to advancing global health outcomes, Arcera bridges investment, talent, and expertise to mitigate complex healthcare challenges while fostering sustainable growth through a diverse portfolio of branded medicines.
Leadership Roles at Arcera
Isabel Afonso - Chief Executive Officer
Isabel Afonso, the Chief Executive Officer at Arcera, directs the overarching strategic vision for the global life sciences organization. Afonso manages the integration of complementary businesses across 90 countries, ensuring the delivery of 2,000 branded medicines to diverse patient populations. By aligning the efforts of 6,500 employees, the Chief Executive Officer drives operational excellence and long-term value creation. Isabel Afonso maintains constant communication with the Board to refine market positioning and address emerging healthcare challenges. This leadership role involves identifying growth opportunities within the pharmaceutical sector to improve human longevity. Through rigorous oversight of international operations, the Chief Executive Officer secures the company's status as a leader in the life sciences industry. Afonso prioritizes sustainable development while expanding the reach of essential therapeutic solutions across four continents, ultimately strengthening the global impact of the organization.
Hany Amin - Chief Financial Officer
Hany Amin, the Chief Financial Officer at Arcera, manages the fiscal health and capital allocation strategies for the global enterprise. Amin oversees financial planning, reporting, and risk management to support the company's expansion across 90 countries. By optimizing resource distribution, the Chief Financial Officer ensures the financial viability of 2,000 branded medicines within the competitive life sciences market. Hany Amin collaborates with executive leadership to evaluate investment opportunities that align with the corporate mission of improving human life. This role involves maintaining transparency with stakeholders and ensuring compliance with international financial regulations. Through precise analysis of market trends, the Chief Financial Officer drives profitability and supports the workforce of 6,500 people. Amin secures the necessary funding for research and development initiatives, directly impacting the ability of the organization to address critical healthcare challenges on a global scale.
Muhanna Essa - Chief People Officer
Muhanna Essa, the Chief People Officer at Arcera, architects the human capital strategy for the global workforce of 6,500 employees. Essa directs talent acquisition, leadership development, and organizational culture initiatives to support the company's mission in the life sciences sector. By fostering an environment of innovation, the Chief People Officer ensures the alignment of human resources with the operational goals of the business across four continents. Muhanna Essa implements programs that enhance employee engagement and retention, which are vital for the successful distribution of 2,000 branded medicines. This leadership role involves collaborating with other C-suite members to build a high-performing team capable of addressing complex healthcare challenges. Through the design of comprehensive training frameworks, the Chief People Officer drives professional growth and organizational agility. Essa maintains a focus on building a diverse and inclusive workplace that reflects the global nature of the company's operations.
Amin Ben Lakhal - Chief Legal Officer
Amin Ben Lakhal, the Chief Legal Officer at Arcera, directs all legal affairs, regulatory compliance, and corporate governance for the global life sciences entity. Lakhal manages complex legal frameworks across 90 countries to protect the intellectual property associated with 2,000 branded medicines. By providing strategic counsel to the executive team, the Chief Legal Officer ensures that all business activities adhere to international healthcare regulations and ethical standards. Amin Ben Lakhal oversees contract negotiations and risk mitigation strategies that safeguard the company's market position. This role involves navigating the intricate legal landscape of the pharmaceutical industry to support sustainable growth and innovation. Through the management of legal teams, the Chief Legal Officer facilitates the seamless operation of the business across four continents. Lakhal secures the integrity of the organization by proactively addressing potential liabilities and ensuring full compliance with global health mandates.
Explore Leadership Teams in Manufacturing
Bausch Health Companies Inc. operates as a global pharmaceutical and healthcare products company focused on developing, manufacturing, and marketing a broad portfolio of branded pharmaceuticals, generic medicines, over-the-counter healthcare products, and medical devices. The organization works to improve patient health outcomes by delivering therapeutic solutions across multiple medical specialties. Through its research, development, and commercial operations, the company serves healthcare providers, hospitals, pharmacies, and patients across numerous international markets. The company functions as a diversified healthcare enterprise with business segments that address several therapeutic and medical device categories. Its core focus areas include gastroenterology, hepatology, neurology, dermatology, dentistry, medical aesthetics, and ophthalmology. By maintaining a broad therapeutic portfolio, the organization supports healthcare professionals in diagnosing, managing, and treating a wide range of medical conditions that affect millions of patients globally.
Company Leadership
JS
TU

Founded in 1971 and headquartered in Hauppauge, New York, Contract Pharmacal (CPC) is a company that manufactures and packages pharmaceuticals, over-the-counter drugs, and dietary supplements for pharmaceutical companies, retailers, and wholesalers worldwide.
Company Leadership MW


Parabolic Drugs Limited is a vertically integrated, research-based pharmaceutical manufacturer and exporter, specializing in the production of over 50 active pharmaceutical ingredients (APIs) and intermediates across various therapeutic segments. The company operates four large-scale facilities, including three state-of-the-art manufacturing plants and a custom synthesis and R&D center. With a focus on backward and forward integration, world-class infrastructure, and strong R&D capabilities, Parabolic Drugs is committed to delivering high-quality products. Their diverse product portfolio is supported by intellectual property rights, including Drug Master Files (DMFs) and patents for novel processes.
Company Leadership VG
AJ
AN
YB
Chemipharm is the only company selling directly to 100% of the reachable pharmacies and hospitals in Egypt. Chemipharm's distribution network includes: 12 branches allover Egypt. 100 fixed routes every day. Total 150 visiting all the pharmacies all over the country. Latest News : PROFILE Company Profile: Chemipharm was founded in 1972 by Dr. Gamal Kamel as the first private sector importer of pharmaceutical products in Egypt. Over the last 35 years, Chemipharm has developed and maintained an invaluable reputation as Egypt's most respectable and high standards pharmaceutical distributor. In 2003, based on the company's continuous growth, Chemipharm has established its own manufacturing facility in the 6th of October Industrial Zone. Plant was designed by Pharma Consult. The modern GMP plant produces pharmaceutical products of all major forms (tablets, capsules, syrups and ointments). Presently Chemipharm is constructing a new sterile area to produce ampoules, eye drops and antibiotics. The company's strategy is based on continuous improvement and growth.
Company Leadership KK
NM
DO